Evidence map›Paper›PMID 22848407›Full record

Trial reportPloS one2012

Do premenopausal women with major depression have low bone mineral density? A 36-month prospective study.

Giovanni Cizza, Sima Mistry, Vi T Nguyen, Farideh Eskandari, Pedro Martinez, Sara Torvik, James C Reynolds, Philip W Gold, Ninet Sinaii, Ninet Sinai and 2 more

Erratum issuedOpen access · goldAbstract readClinical Trial
In one paragraph

Trial report in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 18 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 3 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 3 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Depression and risk of fracture and bone loss: an updated meta-analysis of prospective studies.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2018
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

  • Erratum issued
    Sinai, Ninet [corrected to Sinaii, Ninet]
5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Giovanni CizzaSection on Neuroendocrinology of Obesity, National Institutes of Diabetes and Digestive Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, Maryland, United States of America. cizzag@intra.niddk.nih.gov
Sima Mistry
Vi T Nguyen
Farideh Eskandari
Pedro Martinez
Sara Torvik
James C Reynolds
Philip W Gold
Ninet Sinaii
Ninet Sinai
Gyorgy Csako
POWER Study Group
National Institutes of Health · USNational Institutes of Health Clinical Center · USNational Institute of Diabetes and Digestive and Kidney Diseases · USNational Institute of Mental Health · USTulane University · US

Funding

Pathophysiological Mechanisms in Major Depression and Bipolar DisorderZIAMH002940 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI GOLD, PHILIP W · 2013 to 2014
$10k
Intramural NIH HHS
6 · The paper itself

Abstract

backgroundAn inverse relationship between major depressive disorder (MDD) and bone mineral density (BMD) has been suggested, but prospective evaluation in premenopausal women is lacking.

methodsParticipants of this prospective study were 21 to 45 year-old premenopausal women with MDD (n = 92) and healthy controls (n = 44). We measured BMD at the anteroposterior lumbar spine, femoral neck, total hip, mid-distal radius, trochanter, and Ward's triangle, as well as serum intact parathyroid hormone (iPTH), ionized calcium, plasma adrenocorticotropic hormone (ACTH), serum cortisol, and 24-hour urinary-free cortisol levels at 0, 6, 12, 24, and 36 months. 25-hydroxyvitamin D was measured at baseline.

resultsAt baseline, BMD tended to be lower in women with MDD compared to controls and BMD remained stable over time in both groups. At baseline, 6, 12, and 24 months intact PTH levels were significantly higher in women with MDD vs. controls. At baseline, ionized calcium and 25-hydroxyvitamin D levels were significantly lower in women with MDD compared to controls. At baseline and 12 months, bone-specific alkaline phosphatase, a marker of bone formation, was significantly higher in women with MDD vs. controls. Plasma ACTH was also higher in women with MDD at baseline and 6 months. Serum osteocalcin, urinary N-telopeptide, serum cortisol, and urinary free cortisol levels were not different between the two groups throughout the study.

conclusionWomen with MDD tended to have lower BMD than controls over time. Larger and longer studies are necessary to extend these observations with the possibility of prophylactic therapy for osteoporosis.

trial registrationClinicalTrials.gov NCT 00006180.

Indexed as

Bone DensityAdrenocorticotropic HormoneAdultCalciumCollagen Type IFemaleHumansHydrocortisoneMajor Depressive DisorderMiddle AgedOsteocalcinOsteoporosisParathyroid HormonePeptidesProspective StudiesVitamin D25-hydroxyvitamin DAdrenocorticotropic HormoneCalciumCollagen Type Icollagen type I trimeric cross-linked peptideHydrocortisoneOsteocalcinParathyroid HormonePeptidesVitamin D

Identifiers

PMID22848407
PMCPMC3407177
OpenAlexW2079795809

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.